242 related articles for article (PubMed ID: 29895528)
21. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.
Išić Denčić T; Bartolome A; Šelemetjev S; Đorić I; Tatić S; Živaljević V; Cvejić D
Exp Mol Pathol; 2018 Oct; 105(2):181-189. PubMed ID: 30077672
[TBL] [Abstract][Full Text] [Related]
22. The utility of lymph node mapping sonogram and thyroglobulin surveillance in post thyroidectomy papillary thyroid cancer patients.
Miah CF; Zaman JA; Simon M; Davidov T; Trooskin SZ
Surgery; 2014 Dec; 156(6):1491-6; discussion 1496-7. PubMed ID: 25456939
[TBL] [Abstract][Full Text] [Related]
23. Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma.
Chung SY; Lee JS; Lee H; Park SH; Kim SJ; Ryu HS
Acta Cytol; 2013; 57(3):252-8. PubMed ID: 23636013
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of serum B7-H3 expression, ultrasound and clinical characteristics to predict the risk of cervical lymph node metastases in papillary thyroid carcinoma by nomogram.
Huang Y; Huang Z; Cai H; Zhuge L; Wang S; Yan D; Zhang X; An C; Niu L; Li Z
J Clin Lab Anal; 2023 Jan; 37(1):e24811. PubMed ID: 36525343
[TBL] [Abstract][Full Text] [Related]
25. The clinicopathologic differences of central lymph node metastasis in predicting lateral lymph node metastasis and prognosis in papillary thyroid cancer associated with or without Hashimoto's thyroiditis.
Zhu Y; Zheng K; Zhang H; Chen L; Xue J; Ding M; Wu K; Wang Z; Kong L; Chen X
Tumour Biol; 2016 Jun; 37(6):8037-45. PubMed ID: 26711787
[TBL] [Abstract][Full Text] [Related]
26. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.
Liu Z; Kakudo K; Bai Y; Li Y; Ozaki T; Miyauchi A; Taniguchi E; Mori I
J Clin Pathol; 2011 Apr; 64(4):325-9. PubMed ID: 21296795
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic Analysis of Cathepsin B as a Prognostic Marker of Thyroid Cancer.
Kim EK; Song MJ; Jang HH; Chung YS
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333840
[TBL] [Abstract][Full Text] [Related]
28. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
Paulson L; Shindo M; Schuff K; Corless C
Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
[TBL] [Abstract][Full Text] [Related]
29. Patient's age with papillary thyroid cancer: Is it a key factor for cervical lymph node metastasis?
Wang W; Ding Y; Meng C; Li P; Bai N; Li X
Eur J Surg Oncol; 2023 Jul; 49(7):1147-1153. PubMed ID: 36863913
[TBL] [Abstract][Full Text] [Related]
30. IL-34 is a potential biomarker for the treatment of papillary thyroid cancer.
Zhang P; Zhang H; Dong W; Wang Z; Qin Y; Wu C; Dong Q
J Clin Lab Anal; 2020 Aug; 34(8):e23335. PubMed ID: 32573824
[TBL] [Abstract][Full Text] [Related]
31. [Related factors analysis for lymph node metastasis in papillary thyroid carcinoma: a series of 2 073 patients].
Sun QH; Zhang L; Yang JB; Liu YW; Liang F; Shi H; Liu ZW; Chen G; Chen SG; Shang ZH; Hu SB; Dong YW; Li YL; Li XY
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):592-598. PubMed ID: 28789509
[No Abstract] [Full Text] [Related]
32. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
Zhang M; Wu W; Gao M; Fei Z
Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
[TBL] [Abstract][Full Text] [Related]
33. LIMD2 Is Overexpressed in BRAF V600E-Positive Papillary Thyroid Carcinomas and Matched Lymph Node Metastases.
Pinheiro Dos Santos MJC; Bastos AU; da Costa VR; Delcelo R; Lindsey SC; Colozza-Gama GA; Peng H; Rauscher FJ; Oler G; Cerutti JM
Endocr Pathol; 2018 Sep; 29(3):222-230. PubMed ID: 29560564
[TBL] [Abstract][Full Text] [Related]
34. The binary presence or absence of lymph node metastasis or extrathyroidal extension is not associated with survival in papillary thyroid cancers: Implications for staging systems.
Zhang HS; Lee EK; Jung YS; Nam BH; Park B
Cancer Epidemiol; 2019 Dec; 63():101589. PubMed ID: 31494519
[TBL] [Abstract][Full Text] [Related]
35. Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas.
Jiang K; Li G; Chen W; Song L; Wei T; Li Z; Gong R; Lei J; Shi H; Zhu J
Onco Targets Ther; 2020; 13():1311-1319. PubMed ID: 32103998
[TBL] [Abstract][Full Text] [Related]
36. Role of Lin28A/let-7a/c-Myc Pathway in Growth and Malignant Behavior of Papillary Thyroid Carcinoma.
Huang J; Lin H; Zhong M; Huang J; Sun S; Lin L; Chen Y
Med Sci Monit; 2018 Dec; 24():8899-8909. PubMed ID: 30531691
[TBL] [Abstract][Full Text] [Related]
37. Exosomes increased angiogenesis in papillary thyroid cancer microenvironment.
Wu F; Li F; Lin X; Xu F; Cui RR; Zhong JY; Zhu T; Shan SK; Liao XB; Yuan LQ; Mo ZH
Endocr Relat Cancer; 2019 May; 26(5):525-538. PubMed ID: 30870812
[TBL] [Abstract][Full Text] [Related]
38. Relationship between protein expression of VEGF-C, MMP-2 and lymph node metastasis in papillary thyroid cancer.
Tian X; Cong M; Zhou W; Zhu J; Liu Q
J Int Med Res; 2008; 36(4):699-703. PubMed ID: 18652765
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs and Lymph Node Metastasis in Papillary Thyroid Cancers.
Mutalib NS; Yusof AM; Mokhtar NM; Harun R; Muhammad R; Jamal R
Asian Pac J Cancer Prev; 2016; 17(1):25-35. PubMed ID: 26838219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
